CJC-1295/IPAMORELIN (NO DAC)

Growth Hormone Research • Recovery • Performance Research

CJC-1295 (No DAC) and Ipamorelin are two complementary research peptides that are frequently studied together for their potential role in natural growth hormone signalling. This combination has become a popular area of interest in research involving recovery, body composition, muscle development and metabolic function.

Researchers are investigating how CJC-1295 (No DAC) supports the body's natural release of growth hormone while Ipamorelin selectively activates growth hormone secretagogue receptors. Together, these pathways are being explored for their role in growth hormone pulsatility, protein synthesis, recovery and endocrine function.

The No DAC version of CJC-1295 has a shorter duration of action than the DAC formulation, making it particularly valuable for researchers studying more natural patterns of growth hormone release and peptide signalling.